Wellcome Trust donations made to Institute of Cancer Research

This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of July 2024. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.

Table of contents

Basic donor information

ItemValue
Country United Kingdom
Wikipedia pagehttps://en.wikipedia.org/wiki/Wellcome_Trust
Facebook username wellcometrust
LinkedIn username wellcome-trust
Websitehttps://wellcome.ac.uk/
Donations URLhttps://wellcome.ac.uk/funding/managing-grant/grants-awarded
Twitter usernamewellcometrust
Page on philosophy informing donationshttps://wellcome.ac.uk/about-us/our-strategy
Grant application process pagehttps://wellcome.ac.uk/funding#im-looking-for-funding
Data entry method on Donations List WebsiteSQL insertion commands generated by script https://github.com/riceissa/wellcome-trust

Full donor page for donor Wellcome Trust

Basic donee information

We do not have any donee information for the donee Institute of Cancer Research in our system.

Full donee page for donee Institute of Cancer Research

Donor–donee relationship

Item Value

Donor–donee donation statistics

Cause areaCountMedianMeanMinimum10th percentile 20th percentile 30th percentile 40th percentile 50th percentile 60th percentile 70th percentile 80th percentile 90th percentile Maximum
Overall 79 160,623 682,853 1,520 17,761 141,393 152,502 156,747 160,623 236,934 252,056 903,049 2,218,192 7,962,500
FIXME 79 160,623 682,853 1,520 17,761 141,393 152,502 156,747 160,623 236,934 252,056 903,049 2,218,192 7,962,500

Donation amounts by cause area and year

If you hover over a cell for a given cause area and year, you will get a tooltip with the number of donees and the number of donations.

Note: Cause area classification used here may not match that used by donor for all cases.

Cause area Number of donations Total 2016 2015 2014 2013 2012 2011 2010 2009 2008 2006 2005 2004 2003 2001 2000
FIXME (filter this donor) 79 53,945,416.00 3,140,470.00 5,653,157.00 4,158,660.00 7,930,109.00 7,093,133.00 3,338,765.00 1,277,472.00 6,432,278.00 1,506,199.00 3,797,147.00 50,201.00 179,339.00 1,284,593.00 7,962,500.00 141,393.00
Total 79 53,945,416.00 3,140,470.00 5,653,157.00 4,158,660.00 7,930,109.00 7,093,133.00 3,338,765.00 1,277,472.00 6,432,278.00 1,506,199.00 3,797,147.00 50,201.00 179,339.00 1,284,593.00 7,962,500.00 141,393.00

Graph of spending by cause area and year (incremental, not cumulative)

Graph of spending should have loaded here

Graph of spending by cause area and year (cumulative)

Graph of spending should have loaded here

Full list of documents in reverse chronological order (0 documents)

There are no documents associated with this combination of donor and donee.

Full list of donations in reverse chronological order (79 donations)

Graph of all donations (with known year of donation), showing the timeframe of donations

Graph of donations and their timeframes
Amount (current USD)Amount rank (out of 79)Donation dateCause areaURLInfluencerNotes
63,600.00652016-09-30FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Open access block grant 2016/17. Affected regions: Greater London; affected countries: United Kingdom.
150,000.00602016-08-03FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Drug discovery of a novel Therapeutic Target in Cancer Stem Cells (CSCs). Affected regions: Greater London; affected countries: United Kingdom.
1,176,028.00152016-07-05FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Evolutionary Predictions In Colorectal Cancer (EPICC). Affected regions: Greater London; affected countries: United Kingdom.
239,643.00302016-05-18FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Functional genomic screens to determine initiating and maintenance events in human medulloblastoma. Affected regions: Greater London; affected countries: United Kingdom.
1,505,199.00122016-04-05FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Architectural Role of RNA Polymerase III Promoters and Associated Factors in Shaping and Organising the Human Genome. Affected regions: Greater London; affected countries: United Kingdom.
2,000.00752016-03-31FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Understanding how the p53 oscillations regulates p21 levels in single cells following DNA damage. Affected regions: Greater London; affected countries: United Kingdom.
2,000.00752016-03-31FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Unravelling the genetics of testicular cancer. Affected regions: Greater London; affected countries: United Kingdom.
2,000.00752016-03-31FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Deciphering colorectal cancer risk loci. Affected regions: Greater London; affected countries: United Kingdom.
5,363,815.0022015-11-23FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Designing, developing and delivering integrated foundations for genomic medicine. Affected regions: Greater London; affected countries: United Kingdom.
225,769.00342015-11-19FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Mitigating late adverse effects in free flaps following radiotherapy: an immunomodulatory gene therapy strategy. Affected regions: Greater London; affected countries: United Kingdom.
63,573.00662015-09-21FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Open access awards 2015/16. Affected regions: Greater London; affected countries: United Kingdom.
63,573.00662014-09-15FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Open access publishing costs 2014/15. Affected regions: Greater London; affected countries: United Kingdom.
2,088,670.00102014-07-15FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Evolutionary biology of cancer. Affected regions: Greater London; affected countries: United Kingdom.
2,000.00752014-06-23FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Biomedical Vacation Scholarship. Affected regions: Greater London; affected countries: United Kingdom.
2,004,417.00112014-04-01FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Investigation of circulating tumour DNA in the early detection of KRAS and EGFR mutant cancers. Affected regions: Greater London; affected countries: United Kingdom.
30,774.00692013-11-18FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Addiction to chaperones: Probing the role of HSP70 isoforms in cancer cells. Affected regions: Greater London; affected countries: United Kingdom.
2,797,500.0052013-10-24FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Inhibitors of Lysyl Oxidase for the Prevention and Treatment of Invasive and Metastatic Cancer The enzyme lysyl oxidase (LOX) regulates cross-linking of structural proteins in the extracellular matrix. Affected regions: Greater London; affected countries: United Kingdom.
22,939.00702013-08-30FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Molecular pharmacology of targeted therapy and drug resistance: HSP90 inhibitors. Affected regions: Greater London; affected countries: United Kingdom.
209,857.00362013-06-24FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Molecular pharmacology of targeted therapy and drug resistance: HSP90 inhibitors. Affected regions: Greater London; affected countries: United Kingdom.
223,507.00352013-06-24FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Mechanism-based Drug Discovery. Affected regions: Greater London; affected countries: United Kingdom.
160,623.00402013-06-24FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Mechanism based drug descovery. Affected regions: Greater London; affected countries: United Kingdom.
160,623.00402013-06-24FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Mechanism-based Drug Discovery. Affected regions: Greater London; affected countries: United Kingdom.
160,623.00402013-06-24FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Mechanism-based Drug Discovery. Affected regions: Greater London; affected countries: United Kingdom.
3,040.00732013-06-24FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Biomedical Vacation Scholarship. Affected regions: Greater London; affected countries: United Kingdom.
160,623.00402013-06-24FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Mechanism based drug descovery. Affected regions: Greater London; affected countries: United Kingdom.
4,000,000.0032013-05-23FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Identification of PARP inhibitors for cancer therapy. Affected regions: Greater London; affected countries: United Kingdom.
2,183,584.0092012-11-26FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Genetic and epigenetic investigations of childhood cancer and overgrowth syndromes. Affected regions: Greater London; affected countries: United Kingdom.
230,780.00332012-08-31FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Joint Basic and Clinical PhD Programme at the Institute of Cancer Research. Affected regions: Greater London; affected countries: United Kingdom.
252,056.00242012-08-31FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Joint Basic and Clinical PhD Programme at the Institute of Cancer Research. Affected regions: Greater London; affected countries: United Kingdom.
168,900.00392012-06-27FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- The radioprotection of composite tissue free flaps using ex vivo gene therapy. Affected regions: Greater London; affected countries: United Kingdom.
2,850.00742012-06-25FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Biomedical Vacation Scholarship. Affected regions: Greater London; affected countries: United Kingdom.
159,847.00442012-06-25FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Design and synthesis of Histone Lysine Methyltransferases inhibitors as epigenetic modulators. Affected regions: Greater London; affected countries: United Kingdom.
159,847.00442012-06-25FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Investigation of Tankyrase Inhibitors to Block Wnt Signalling as a TherapeuticStrategy for Sarcomas. Affected regions: Greater London; affected countries: United Kingdom.
159,847.00442012-06-25FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Addiction to chaperones: Probing the role of HSP70 isoforms in cancer cells. Affected regions: Greater London; affected countries: United Kingdom.
159,847.00442012-06-25FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Design and synthesis of medium-ring compounds to target nucleotide binding sites. Affected regions: Greater London; affected countries: United Kingdom.
250,000.00252012-05-28FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Quantitative proteomic dissection of genetic aberrations In PDAC development. Affected regions: Greater London; affected countries: United Kingdom.
394,250.00192012-05-22FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- A facility for in-house analysis and X-ray data collection of crystals with large subunit cells. Affected regions: Greater London; affected countries: United Kingdom.
2,673,048.0062012-04-17FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Using Genetics in Mainstream Medicine to Deliver Personalised Care for Cancer Patients. Affected regions: Greater London; affected countries: United Kingdom.
257,577.00222012-04-16FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Identification of genes involved in the differentiation of liposarcomas as novel therapeutic targets. Affected regions: Greater London; affected countries: United Kingdom.
17,761.00722012-01-27FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Understanding the HSF1 pathway and its potential for cancer therapy. Affected regions: Greater London; affected countries: United Kingdom.
22,939.00702012-01-27FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Targeting the molecular chaperones in castration resistant prostate cancer. Affected regions: Greater London; affected countries: United Kingdom.
243,585.00292011-11-30FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Exploiting the contributions of PI3-kinase signalling and EZH2 histone methyltransferase to drug resistance and tumorigenesis in glioblastoma. Affected regions: Greater London; affected countries: United Kingdom.
156,747.00482011-08-31FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Synthesis and biological evaluation of CRAF inhibitors. Affected regions: Greater London; affected countries: United Kingdom.
156,747.00482011-08-31FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Design and synthesis of small molecule inhibitors of NEK family Ser/Thr protein kinases. Affected regions: Greater London; affected countries: United Kingdom.
156,747.00482011-08-31FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Identifying the molecular targets of inhibitors of androgen receptor mediated transcription by photoaffinity labelling. Affected regions: Greater London; affected countries: United Kingdom.
156,747.00482011-08-31FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Understanding the HSF1 pathway and its potential for cancer therapy. Affected regions: Greater London; affected countries: United Kingdom.
250,000.00252011-05-23FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- The assembly mechanism of higher order protein assemblies. Affected regions: Greater London; affected countries: United Kingdom.
2,218,192.0082011-05-10FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Understanding the structure and mechanism of macromolecular machines that regulate chromatin dynamics. Affected regions: Greater London; affected countries: United Kingdom.
236,934.00312010-09-21FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Targeting the molecular chaperones in castration resistant prostate cancer. Affected regions: Greater London; affected countries: United Kingdom.
236,934.00312010-09-21FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Joint Basic and Clinical PhD Programme at the Institute of Cancer Research. Affected regions: Greater London; affected countries: United Kingdom.
153,466.00522010-08-31FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Determining modifiers of cdk inhibitor sensitivity. Affected regions: Greater London; affected countries: United Kingdom.
153,466.00522010-07-13FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- ATP mimetics as inhibitors and probes of ATPases. Affected regions: Greater London; affected countries: United Kingdom.
153,466.00522010-07-13FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Developmemt of specific RNAse inhibitors for the treatment of haematological cancers. Affected regions: Greater London; affected countries: United Kingdom.
153,466.00522010-07-13FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Structual and chemical biology in the design of selective kinase inhibitors. Affected regions: Greater London; affected countries: United Kingdom.
188,220.00372010-07-06FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Evaluation and Qualification of Non-Invasive MRI Biomarkers Associated with Platelet-Derived Growth Factor (PDGF) Signalling In Vivo. Affected regions: Greater London; affected countries: United Kingdom.
1,520.00792010-06-14FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Biomedical Vacation Scholarship. Affected regions: Greater London; affected countries: United Kingdom.
254,047.00232009-10-20FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Wellcome Trust Joint Basic and Clinical PhD Programme at the Institute of Cancer Research: 'Study of biomarkers in solid tumours including malignant melanoma and colon carcinoma by LC-MS metabonomics'. Affected regions: Greater London; affected countries: United Kingdom.
245,735.00282009-10-20FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Wellcome Trust Joint Basic and Clinical PhD Programme at the Institute of Cancer Research. Affected regions: Greater London; affected countries: United Kingdom.
903,049.00162009-06-23FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- A systems genetics analysis of Rho-family GTPase signalling. Affected regions: Greater London; affected countries: United Kingdom.
152,502.00562009-06-08FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Developing selective inhibitors of P70S6K from an understanding of the molecular determinants of intra-family AGC kinase inhibitor selectivity using PKA chimeric protein. Affected regions: Greater London; affected countries: United Kingdom.
152,502.00562009-06-08FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Structural & functional studies of DOCK-family guanine nucleotide exchange factors. Affected regions: Greater London; affected countries: United Kingdom.
152,502.00562009-06-08FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Structural & functional investigation of potential drug targets in metastatic melanoma. Affected regions: Greater London; affected countries: United Kingdom.
152,502.00562009-06-08FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Synthesis of cancer targeting compounds derived from a fragment-based approach. Affected regions: Greater London; affected countries: United Kingdom.
250,000.00252009-05-27FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Development of mass spectrometry tools to study signaling networks in vivo. Affected regions: Greater London; affected countries: United Kingdom.
716,043.00172009-04-01FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- A Genome-wide association study in childhood kidney cancer (Wilms tumor) . Affected regions: Greater London; affected countries: United Kingdom.
3,453,396.0042009-03-30FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Inhibitors of Lysyl Oxidase for the Prevention and Treatment of Invasive and Metastatic Cancer. Affected regions: Greater London; affected countries: United Kingdom.
148,911.00612008-09-16FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- New structural templates for kinase inhibition. Affected regions: Greater London; affected countries: United Kingdom.
148,911.00612008-09-16FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Integration, application and development of biophysical techniques in structure based drug discovery. Affected regions: Greater London; affected countries: United Kingdom.
272,566.00212008-09-16FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Histone methyltransferase Prmt1 in normal development and cancer therapeutics. Affected regions: Greater London; affected countries: United Kingdom.
148,911.00612008-09-16FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Targeted disruption of TPR-Domain recruitment to the Hsp90/Hsp70 molecular chaperone systems. Affected regions: Greater London; affected countries: United Kingdom.
457,150.00182008-01-12FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- A genome-wide screen of SNPs to identify susceptibility alleles for adult glioma. Affected regions: Greater London; affected countries: United Kingdom.
329,750.00202008-01-12FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- A second generation genome-side-association study in breast cancer. Affected regions: Greater London; affected countries: United Kingdom.
1,504,955.00132006-06-27FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Mechanisms of client protein activation, regulation and targeted destruction by the Hsp90 molecular chaperone system. Affected regions: Greater London; affected countries: United Kingdom.
2,292,192.0072006-04-28FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Development of 2 series of systemic/oral inhibitors of mutant B-RAF in melanoma. Affected regions: Greater London; affected countries: United Kingdom.
50,201.00682005-01-20FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Development of a clinical candidate for cancer that is selective for a mutant form of the target. Affected regions: Greater London; affected countries: United Kingdom.
179,339.00382004-07-06FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Structural studies of argonaute proteins involved in gene silencing. Affected regions: Greater London; affected countries: United Kingdom.
1,284,593.00142003-04-16FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Development of a clinical candidate for cancer that is selective for a mutant form of the target. Affected regions: Greater London; affected countries: United Kingdom.
7,962,500.0012001-09-12FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Cancer Genomics Centre Development: Laboratories and Support Facilities. Affected regions: Greater London; affected countries: United Kingdom.
141,393.00642000-10-02FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Identification of predisposition genes for multiple leiomyomas. Affected regions: Greater London; affected countries: United Kingdom.